Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Equity (2017 - 2025)

Historic Return on Equity for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 0.04%.

  • Organogenesis Holdings' Return on Equity fell 100.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.04% for FY2024, which is 500.0% down from last year.
  • Organogenesis Holdings' Return on Equity amounted to 0.04% in Q3 2025, which was down 100.0% from 0.08% recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Return on Equity high stood at 0.44% for Q4 2021, and its period low was 0.11% during Q1 2025.
  • For the 5-year period, Organogenesis Holdings' Return on Equity averaged around 0.12%, with its median value being 0.05% (2023).
  • In the last 5 years, Organogenesis Holdings' Return on Equity skyrocketed by 12600bps in 2021 and then crashed by -3800bps in 2022.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Return on Equity stood at 0.44% in 2021, then plummeted by -86bps to 0.06% in 2022, then crashed by -70bps to 0.02% in 2023, then tumbled by -304bps to 0.04% in 2024, then dropped by -9bps to 0.04% in 2025.
  • Its Return on Equity was 0.04% in Q3 2025, compared to 0.08% in Q2 2025 and 0.11% in Q1 2025.